[1]
2009. Pegylated, liposomal doxorubicin in the treatment of primary cutaneous T-cell lymphoma: an update. Hematology Meeting Reports (formerly Haematologica Reports). 3, 1 (Jun. 2009). DOI:https://doi.org/10.4081/hmr.v3i1.543.